The debt of Royalty Pharma plc over the past 8 years
Chart Royalty Pharma plc: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Royalty Pharma plc had liquid cash of $637.5M and total debt of $8.95B: net debt of $8.31B. It had more debt than liquid cash at all 8 year-ends shown. Total debt was highest at the end of fiscal 2025 ($8.95B) and lowest at the end of fiscal 2020 ($5.82B).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $637.5M* | $8.95B | -$8.31B |
| 2024ended Dec 31, 2024 | $987.23M* | $7.61B | -$6.63B |
| 2023ended Dec 31, 2023 | $495.31M* | $6.14B | -$5.64B |
| 2022ended Dec 31, 2022 | $1.74B* | $7.12B | -$5.38B |
| 2021ended Dec 31, 2021 | $2.19B* | $7.1B | -$4.91B |
| 2020ended Dec 31, 2020 | $2.06B* | $5.82B | -$3.75B |
| 2019ended Dec 31, 2019 | $340.65M* | $6.24B | -$5.9B |
| 2018ended Dec 31, 2018 | $1.92B | $6.52B | -$4.6B |
Fiscal years as Royalty Pharma plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Royalty Pharma plc
- The revenue of Royalty Pharma plc
- The profitability of Royalty Pharma plc
- All of Royalty Pharma plc's financials, charted
Companies of a similar size
- UIUBIQUITI INC.
- ACGLARCH CAPITAL GROUP LTD.
- CBOECboe Global Markets, Inc.
- EXPEEXPEDIA GROUP, INC.
- CCLCarnival Corp Ltd.
Not investment advice. This page shows what Royalty Pharma plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.